CATX Q1 EPS Decreased by Brookline Capital Management
Perspective Therapeutics, Inc. (NYSE:CATX – Free Report) – Research analysts at Brookline Capital Management decreased their Q1 2025 earnings per share estimates for Perspective Therapeutics in a report issued on Wednesday, March 26th. Brookline Capital Management analyst K. Dolliver now anticipates that the company will post earnings per share of ($0.30) for the quarter, down […]
Perspective Therapeutics, Inc. (NYSE:CATX – Free Report) – Research analysts at Brookline Capital Management decreased their Q1 2025 earnings per share estimates for Perspective Therapeutics in a report issued on Wednesday, March 26th. Brookline Capital Management analyst K. Dolliver now anticipates that the company will post earnings per share of ($0.30) for the quarter, down […]
